Medpace Holdings Operating Expenses Growth & History (MEDP)
Medpace Holdings's operating expenses was $2.00B for fiscal 2025.
View full Medpace Holdings company overviewMedpace Holdings annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.00B | $333.1M | +20.04% |
| 2024 | 2024-12-31 | $1.66B | $113.2M | +7.31% |
| 2023 | 2023-12-31 | $1.55B | $367.7M | +31.13% |
| 2022 | 2022-12-31 | $1.18B | $237.5M | +25.17% |
| 2021 | 2021-12-31 | $943.8M | $184.9M | +24.36% |
| 2020 | 2020-12-31 | $758.9M | $25.2M | +3.43% |
| 2019 | 2019-12-31 | $733.7M | $130.2M | +21.57% |
| 2018 | 2018-12-31 | $603.5M | $232.2M | +62.55% |
| 2017 | 2017-12-31 | $371.3M | $2.2M | +0.60% |
| 2016 | 2016-12-31 | $369.1M | $30.6M | +9.04% |
| 2015 | 2015-12-31 | $338.5M | — | — |
Medpace Holdings quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $560.5M | $83.5M | +17.51% |
| Q1 2026 | 2026-03-31 | $565.1M | $120.1M | +26.98% |
| Q4 2025 | 2025-12-31 | $555.2M | $144.0M | +35.01% |
| Q3 2025 | 2025-09-30 | $518.1M | $97.1M | +23.05% |
| Q2 2025 | 2025-06-30 | $477.0M | $54.0M | +12.77% |
| Q1 2025 | 2025-03-31 | $445.0M | $38.1M | +9.35% |
| Q4 2024 | 2024-12-31 | $411.2M | $130,000 | +0.03% |
| Q3 2024 | 2024-09-30 | $421.0M | $13.5M | +3.30% |
| Q2 2024 | 2024-06-30 | $423.0M | $40.5M | +10.58% |
| Q1 2024 | 2024-03-31 | $407.0M | $59.1M | +16.99% |
| Q4 2023 | 2023-12-31 | $411.1M | $93.4M | +29.41% |
| Q3 2023 | 2023-09-30 | $407.6M | $101.7M | +33.24% |
| Q2 2023 | 2023-06-30 | $382.5M | $91.5M | +31.45% |
| Q1 2023 | 2023-03-31 | $347.9M | $81.1M | +30.41% |
| Q4 2022 | 2022-12-31 | $317.7M | $64.0M | +25.22% |
| Q3 2022 | 2022-09-30 | $305.9M | $64.1M | +26.49% |
| Q2 2022 | 2022-06-30 | $291.0M | $55.1M | +23.37% |
| Q1 2022 | 2022-03-31 | $266.7M | $54.4M | +25.61% |
| Q4 2021 | 2021-12-31 | $253.7M | $49.0M | +23.94% |
| Q3 2021 | 2021-09-30 | $241.9M | $57.9M | +31.48% |
| Q2 2021 | 2021-06-30 | $235.8M | $61.0M | +34.87% |
| Q1 2021 | 2021-03-31 | $212.4M | $17.0M | +8.70% |
| Q4 2020 | 2020-12-31 | $204.7M | $10.9M | +5.64% |
| Q3 2020 | 2020-09-30 | $184.0M | −$2.3M | −1.23% |
| Q2 2020 | 2020-06-30 | $174.9M | −$4.0M | −2.22% |
| Q1 2020 | 2020-03-31 | $195.4M | $20.5M | +11.74% |
| Q4 2019 | 2019-12-31 | $193.8M | $32.3M | +20.02% |
| Q3 2019 | 2019-09-30 | $186.2M | $33.9M | +22.26% |
| Q2 2019 | 2019-06-30 | $178.8M | $32.0M | +21.83% |
| Q1 2019 | 2019-03-31 | $174.8M | $31.9M | +22.31% |
| Q4 2018 | 2018-12-31 | $161.4M | $64.2M | +66.02% |
| Q3 2018 | 2018-09-30 | $152.3M | $58.9M | +63.02% |
| Q2 2018 | 2018-06-30 | $146.8M | $56.9M | +63.22% |
| Q1 2018 | 2018-03-31 | $143.0M | $52.3M | +57.67% |
| Q4 2017 | 2017-12-31 | $97.2M | $1.9M | +1.98% |
| Q3 2017 | 2017-09-30 | $93.4M | −$1.7M | −1.82% |
| Q2 2017 | 2017-06-30 | $89.9M | −$1.9M | −2.07% |
| Q1 2017 | 2017-03-31 | $90.7M | $4.0M | +4.56% |
| Q4 2016 | 2016-12-31 | $95.4M | — | — |
| Q3 2016 | 2016-09-30 | $95.2M | $10.2M | +12.06% |
| Q2 2016 | 2016-06-30 | $91.8M | — | — |
| Q1 2016 | 2016-03-31 | $86.7M | — | — |
| Q3 2015 | 2015-09-30 | $84.9M | — | — |
Medpace Holdings operating expenses trends
Over the last five fiscal years, Medpace Holdings's operating expenses increased from $758.9M to $2.00B, a change of $1.24B. The latest reported quarter, Q2 2026, shows $560.5M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medpace Holdings source filings ↗